Macitentan and Tadalafil Combination Therapy in Incident and Prevalent Pulmonary Arterial Hypertension: Real-World Evidence from the OPUS/OrPHeUS Studies

By sjmartinez • September 25, 2024

Chin KM, Channick R, Kim NH, MacDonald G, Ong R, Martin N, Senatore A, McLaughlin VV. Macitentan and Tadalafil Combination Therapy in Incident and Prevalent Pulmonary Arterial Hypertension: Real-World Evidence from the OPUS/OrPHeUS Studies. Adv Ther. 2024 Sep 24. doi: 10.1007/s12325-024-02964-0. Epub ahead of print. PMID: 39316293.

Tags: combination therapy, Incident, Macitentan, Prevalent, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine, real-world data, safety, survival, Tadalafil

Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV

Zanni MV, Umbleja T, Fichtenbaum CJ, Fitch KV, McCallum S, Aberg JA, Overton ET, Malvestutto CD, Bloomfield GS, Currier JS, Schnittman SR, Erlandson KM, Diggs[...]

Social genomics, cognition, and well-being during the COVID-19 pandemic

Bateman JR, Krishnamurthy S, Quillen EE, Waugh CE, Kershaw KN, Lockhart SN, Hughes TM, Seeman TE, Cole SW, Craft S. Social genomics, cognition, and well-being[...]

Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECT

Finn RS, Qin S, Piscaglia F, Evans TRJ, Knox JJ, López López C, Ramji Z, Ren M, Mody K, Vogel A, Kudo M. Characterization of[...]